無針ドラッグデリバリーデバイスの世界市場レポート 2025年

無針ドラッグデリバリーデバイス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.5％で288億6,000万米ドルに成長します。予測期間の成長は、無痛投薬に対する需要の増加、患者中心のヘルスケアソリューションの重視の高まり、小児・老年人口におけるアプリケーションの拡大、頻繁な注射を必要とする慢性疾患の有病率の上昇、機器の効率と使いやすさを向上させる技術の進歩、新興市場における医療アクセスの拡大、革新的な送達システムの研究開発への投資の拡大に起因すると考えられます。予測期間における主な動向としては、ウェアラブルデバイスやコネクテッドデバイスの採用拡大、新規マイクロ流体技術の出現、小児に優しい無針ソリューションへの注目の高まり、人工知能や機械学習アルゴリズムの統合、在宅ヘルスケア環境におけるアプリケーションの拡大などが挙げられます。

糖尿病の有病率の増加は、今後数年間における無針ドラッグデリバリーデバイス市場の拡大を促進すると予想されます。糖尿病は、血糖値の上昇を特徴とする慢性疾患であり、インスリンの分泌不足やインスリンを効果的に使用できない体質が原因です。糖尿病患者の増加は、座りがちなライフスタイル、食生活の乱れ、遺伝的要因、都市化、高齢化、ヘルスケアへのアクセス制限、世界の肥満率の増加などの要因に起因しています。無針ドラッグデリバリーデバイスは、糖尿病管理において従来のインスリン注射に代わるものを提供します。ジェットインジェクターや経皮パッチを含むこれらのデバイスは、針を刺すことなく皮膚からインスリンを投与するため、注射に伴う不快感や不安を軽減し、ユーザーの快適性を向上させる。例えば、2024年6月、英国の国民保健サービス（National Health Service）は、2023年にイングランドで50万人以上（54万9,000人）が2型糖尿病を発症するリスクがあることが判明し、GPに登録された非糖尿病性高血糖（糖尿病予備軍）の総数が361万5,330人になったと報告しました。これは、2022年の306万5,825人から20％近く増加したことになり、糖尿病罹患率の増加を浮き彫りにしています。その結果、糖尿病有病率の上昇が無針ドラッグデリバリーデバイス市場の成長に拍車をかけています。

無針ドラッグデリバリーデバイス市場の有力企業は、デュアルチャンバー吸入器などの革新的なソリューションに注力し、患者と医療提供者の進化するニーズに対応することで、有効性と投与の容易性を高めています。デュアルチャンバー吸入器は、異なる薬剤を別々に保持できる2つのコンパートメントで構成され、合理化された治療と患者の利便性向上のために、1つのデバイスで複数の薬剤の組み合わせを容易にします。例えば、米国を拠点とするプラスチック製造会社ベリー・世界社は、2024年4月、患者中心のヘルスケアソリューションに革命をもたらすよう設計された最先端のドライパウダー吸入器（DPI）であるベリーヘーラーを発表しました。ドーズカウンターを備えたこのデュアルチャンバー吸入器は、正確な薬剤投与を保証し、複雑な吸入治療に理想的な金属部品を使用しないオールプラスチック構造を特徴としています。便利で衛生的な双方向マウスピースカバーや、適切な使用を示す可聴信号などの高度な機能により、ユーザーエクスペリエンスが向上します。内蔵のドーズカウンターは、薬剤の使用量を正確にモニターし、投与ミスを最小限に抑えます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界無針ドラッグデリバリーデバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の無針ドラッグデリバリーデバイス市場：成長率分析
• 世界の無針ドラッグデリバリーデバイス市場の実績：規模と成長, 2019-2024
• 世界の無針ドラッグデリバリーデバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界無針ドラッグデリバリーデバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の無針ドラッグデリバリーデバイス市場：デバイスタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 吸入器
• ジェットインジェクター
• 新しい針
• 経皮パッチ
• その他のデバイスタイプ
• 世界の無針ドラッグデリバリーデバイス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• ワクチンの配送
• 小児用注射
• インスリン投与
• その他の用途
• 世界の無針ドラッグデリバリーデバイス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 在宅ヘルスケア
• 世界の無針ドラッグデリバリーデバイス市場吸入器の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドライパウダー吸入器（DPI）
• 定量噴霧式吸入器（MDI）
• ネブライザー
• 世界の無針ドラッグデリバリーデバイス市場ジェットインジェクターのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高圧ジェットインジェクター
• スプリング式ジェットインジェクター
• バッテリー駆動式ジェットインジェクター
• 世界の無針ドラッグデリバリーデバイス市場、新規針のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロニードルアレイ
• ナノニードルアレイ
• 世界の無針ドラッグデリバリーデバイス市場経皮パッチの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロニードルパッチ
• 従来のパッチ（ニコチン、ホルモン、鎮痛剤）
• 世界の無針ドラッグデリバリーデバイス市場、その他のデバイスタイプのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口ドラッグデリバリーデバイス
• 埋め込み型ドラッグデリバリーシステム
• 舌下ドラッグデリバリーデバイス

第7章 地域別・国別分析

• 世界の無針ドラッグデリバリーデバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の無針ドラッグデリバリーデバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 無針ドラッグデリバリーデバイス市場：競合情勢
• 無針ドラッグデリバリーデバイス市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novo Nordisk AS
• Becton, Dickinson and Company
• Endo International plc
• Insulet Corporation
• Purdue Pharma L.P.
• Antares Pharma Inc.
• MannKind Corporation
• Med-Jet Inc.
• Portal Instruments
• PharmaJet
• Inovio Pharmaceuticals, Inc.
• National Medical Products Inc.
• Mika Medical Co. Ltd.
• Medical International Technology Inc.（MTI）
• NanoPass Technologies Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 無針ドラッグデリバリーデバイス市場2029：新たな機会を提供する国
• 無針ドラッグデリバリーデバイス市場2029：新たな機会を提供するセグメント
• 無針ドラッグデリバリーデバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Needle-free drug delivery devices are medical tools designed to administer medication without the use of traditional needles. They provide an alternative method for delivering drugs, vaccines, or therapeutic agents into the body through the skin or mucosal membranes, aiming to reduce patient discomfort and the risk of needle-related injuries.

The primary types of needle-free drug delivery devices include inhalers, jet injectors, novel needles, transdermal patches, and others. Inhalers are portable devices that deliver medication directly into the lungs through a mist or spray. They find applications in various areas such as pain management, vaccine delivery, pediatric injections, insulin delivery, among others, and are utilized by a range of end-users including hospitals and clinics, as well as home healthcare settings.

The needle-free drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides needle-free drug delivery devices market statistics, including needle-free drug delivery devices industry global market size, regional shares, competitors with a needle-free drug delivery devices market share, detailed needle-free drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the needle-free drug delivery devices industry. This needle-free drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The needle-free drug delivery devices market size has grown rapidly in recent years. It will grow from $16.7 billion in 2024 to $18.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for painless drug delivery methods, high geriatric population, emphasis on patient compliance and safety, regulatory support for needle-free technologies, and expanded pharmaceutical industry.

The needle-free drug delivery devices market size is expected to see rapid growth in the next few years. It will grow to $28.86 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing demand for painless medication administration, growing emphasis on patient-centric healthcare solutions, expanding applications in pediatric and geriatric populations, rising prevalence of chronic diseases necessitating frequent injections, technological advancements enhancing device efficiency and usability, expanding access to healthcare in emerging markets, and growing investments in research and development for innovative delivery systems. Major trends in the forecast period include increased adoption of wearable and connected devices, the emergence of novel microfluidic technologies, a growing focus on pediatric-friendly needle-free solutions, the integration of artificial intelligence and machine learning algorithms, and expanding applications in home healthcare settings.

The growing prevalence of diabetes is expected to drive the expansion of the needle-free drug delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels, resulting from insufficient insulin production or the body's inability to effectively use insulin. The rise in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, genetic factors, urbanization, aging populations, limited healthcare access, and increasing obesity rates globally. Needle-free drug delivery devices offer an alternative to traditional insulin injections in diabetes management. These devices, including jet injectors and transdermal patches, administer insulin through the skin without the need for needles, reducing the discomfort and anxiety associated with injections while improving user comfort. For instance, in June 2024, the UK's National Health Service reported that in 2023, over half a million (549,000) more individuals in England were found to be at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents an increase of nearly 20% from 3,065,825 in 2022, highlighting the growing incidence of diabetes. Consequently, the rising prevalence of diabetes is fueling the growth of the needle-free drug delivery device market.

Prominent companies in the needle-free drug delivery device market are concentrating on innovative solutions such as dual-chamber inhalers to enhance effectiveness and ease of administration, addressing the evolving needs of patients and healthcare providers. A dual-chamber inhaler comprises two compartments capable of holding different medications separately, facilitating the combination of multiple drugs in a single device for streamlined treatment and enhanced patient convenience. For instance, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler in April 2024, a state-of-the-art dry powder inhaler (DPI) designed to revolutionize patient-centered healthcare solutions. Equipped with a dose counter, this dual-chamber inhaler ensures precise medication administration and features an all-plastic construction devoid of metal parts, ideal for complex inhalation treatments. Advanced functionalities such as a bi-directional mouthpiece cover for convenience and hygiene, along with audible signals indicating proper usage, enhance user experience. The integrated dose counter facilitates accurate monitoring of medication usage, minimizing dosage errors.

In May 2022, Halozyme Therapeutics Inc., a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million, aiming to strengthen its position as a leading drug delivery company. Leveraging Antares' auto-injector platform and specialty commercial business, Halozyme expands its strategy to include specialty products, accelerating long-term revenue growth. Antares Pharma Inc., a US-based pharmaceutical company, specializes in developing needle-free injectors used for insulin delivery in diabetes treatment.

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the needle-free drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The needle-free drug delivery devices market consists of sales of nasal sprays, buccal patches, and oral inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Needle-Free Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on needle-free drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for needle-free drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The needle-free drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Device Type: Inhalers; Jet Injectors; Novel Needles; Transdermal Patches; Other Device Types
• 2) By Application: Pain Management; Vaccine Delivery; Pediatric Injections; Insulin Delivery; Other Applications
• 3) By End-User: Hospitals And Clinics; Home Healthcare
• Subsegments:
• 1) By Inhalers: Dry Powder Inhalers (Dpi); Metered Dose Inhalers (Mdi); Nebulizers
• 2) By Jet Injectors: High-Pressure Jet Injectors; Spring-Powered Jet Injectors; Battery-Operated Jet Injectors
• 3) By Novel Needles: Micro-Needle Arrays; Nano-Needle Arrays
• 4) By Transdermal Patches: Microneedle Patches; Conventional Patches ( Nicotine, Hormonal, Pain Relief)
• 5) By Other Device Types: Oral Drug Delivery Devices; Implantable Drug Delivery Systems; Sublingual Drug Delivery Devices
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; 3M Company; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Needle-Free Drug Delivery Devices Market Characteristics

3. Needle-Free Drug Delivery Devices Market Trends And Strategies

4. Needle-Free Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Needle-Free Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Needle-Free Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Needle-Free Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Needle-Free Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Needle-Free Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Needle-Free Drug Delivery Devices Total Addressable Market (TAM)

6. Needle-Free Drug Delivery Devices Market Segmentation

• 6.1. Global Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inhalers
• Jet Injectors
• Novel Needles
• Transdermal Patches
• Other Device Types
• 6.2. Global Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Vaccine Delivery
• Pediatric Injections
• Insulin Delivery
• Other Applications
• 6.3. Global Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Home Healthcare
• 6.4. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dry Powder Inhalers (DPI)
• Metered Dose Inhalers (MDI)
• Nebulizers
• 6.5. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Pressure Jet Injectors
• Spring-Powered Jet Injectors
• Battery-Operated Jet Injectors
• 6.6. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Novel Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Micro-Needle Arrays
• Nano-Needle Arrays
• 6.7. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Transdermal Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microneedle Patches
• Conventional Patches (Nicotine, Hormonal, Pain Relief)
• 6.8. Global Needle-Free Drug Delivery Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Drug Delivery Devices
• Implantable Drug Delivery Systems
• Sublingual Drug Delivery Devices

7. Needle-Free Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Needle-Free Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Needle-Free Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Needle-Free Drug Delivery Devices Market

• 8.1. Asia-Pacific Needle-Free Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Needle-Free Drug Delivery Devices Market

• 9.1. China Needle-Free Drug Delivery Devices Market Overview
• 9.2. China Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Needle-Free Drug Delivery Devices Market

• 10.1. India Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Needle-Free Drug Delivery Devices Market

• 11.1. Japan Needle-Free Drug Delivery Devices Market Overview
• 11.2. Japan Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Needle-Free Drug Delivery Devices Market

• 12.1. Australia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Needle-Free Drug Delivery Devices Market

• 13.1. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Needle-Free Drug Delivery Devices Market

• 14.1. South Korea Needle-Free Drug Delivery Devices Market Overview
• 14.2. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Needle-Free Drug Delivery Devices Market

• 15.1. Western Europe Needle-Free Drug Delivery Devices Market Overview
• 15.2. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Needle-Free Drug Delivery Devices Market

• 16.1. UK Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Needle-Free Drug Delivery Devices Market

• 17.1. Germany Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Needle-Free Drug Delivery Devices Market

• 18.1. France Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Needle-Free Drug Delivery Devices Market

• 19.1. Italy Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Needle-Free Drug Delivery Devices Market

• 20.1. Spain Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Needle-Free Drug Delivery Devices Market

• 21.1. Eastern Europe Needle-Free Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Needle-Free Drug Delivery Devices Market

• 22.1. Russia Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Needle-Free Drug Delivery Devices Market

• 23.1. North America Needle-Free Drug Delivery Devices Market Overview
• 23.2. North America Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Needle-Free Drug Delivery Devices Market

• 24.1. USA Needle-Free Drug Delivery Devices Market Overview
• 24.2. USA Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Needle-Free Drug Delivery Devices Market

• 25.1. Canada Needle-Free Drug Delivery Devices Market Overview
• 25.2. Canada Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Needle-Free Drug Delivery Devices Market

• 26.1. South America Needle-Free Drug Delivery Devices Market Overview
• 26.2. South America Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Needle-Free Drug Delivery Devices Market

• 27.1. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Needle-Free Drug Delivery Devices Market

• 28.1. Middle East Needle-Free Drug Delivery Devices Market Overview
• 28.2. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Needle-Free Drug Delivery Devices Market

• 29.1. Africa Needle-Free Drug Delivery Devices Market Overview
• 29.2. Africa Needle-Free Drug Delivery Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Needle-Free Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Needle-Free Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Needle-Free Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Needle-Free Drug Delivery Devices Market Competitive Landscape
• 30.2. Needle-Free Drug Delivery Devices Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Needle-Free Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. Novo Nordisk AS
• 31.2. Becton, Dickinson and Company
• 31.3. Endo International plc
• 31.4. Insulet Corporation
• 31.5. Purdue Pharma L.P.
• 31.6. Antares Pharma Inc.
• 31.7. MannKind Corporation
• 31.8. Med-Jet Inc.
• 31.9. Portal Instruments
• 31.10. PharmaJet
• 31.11. Inovio Pharmaceuticals, Inc.
• 31.12. National Medical Products Inc.
• 31.13. Mika Medical Co. Ltd.
• 31.14. Medical International Technology Inc. (MTI)
• 31.15. NanoPass Technologies Ltd.

32. Global Needle-Free Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Needle-Free Drug Delivery Devices Market

34. Recent Developments In The Needle-Free Drug Delivery Devices Market

35. Needle-Free Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Needle-Free Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Needle-Free Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Needle-Free Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer